Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study)

详细信息    查看全文

• 作者：Steffen Schmitz-Valckenberg ; MD¹ ; ⁷ ; José ; -Alain Sahel ; MD² ; Ronald Danis ; MD³ ; Monika Fleckenstein ; MD¹ ; Glenn J. Jaffe ; MD⁴ ; Sebastian Wolf ; MD⁵ ; Christian Pruente ; MD⁶ ; Frank G. Holz ; MD¹ ; ⁷ ; ^{Frank.Holz@ukb.uni-bonn.de" class="auth_mail" title="E-mail the corresponding author}
• 关键词：AMD ; age-related macular degeneration ; BCVA ; best-corrected visual acuity ; CFP ; color fundus photography ; DA ; disc areas ; FAF ; fundus autofluorescence ; FAM ; Fundus Autofluorescence Imaging in Age-Related Macular Degeneration ; GA ; geographic atrophy ; GAP ; Geographic Atrophy Progression ; GATE ; Geographic Atrophy Treatment Evaluation ; RPE ; retinal pigment epithelium ; SE ; standard error
• 刊名：Ophthalmology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：123
• 期：2
• 页码：361-368
• 全文大小：1359 K

文摘

The Geographic Atrophy Progression (GAP) study was designed to assess the rate of geographic atrophy (GA) progression and to identify prognostic factors by measuring the enlargement of the atrophic lesions using fundus autofluorescence (FAF) and color fundus photography (CFP).

Design

Prospective, multicenter, noninterventional natural history study.

Participants

A total of 603 participants were enrolled in the study; 413 of those had gradable lesion data from FAF or CFP, and 321 had gradable lesion data from both FAF and CFP.

Methods

Atrophic lesion areas were measured by FAF and CFP to assess lesion progression over time. Lesion size assessments and best-corrected visual acuity (BCVA) were conducted at screening/baseline (day 0) and at 3 follow-up visits: month 6, month 12, and month 18 (or early exit).

Main Outcome Measures

The GA lesion progression rate in disease subgroups and mean change from baseline visual acuity.

Results

Mean (standard error) lesion size changes from baseline, determined by FAF and CFP, respectively, were 0.88 (0.1) and 0.78 (0.1) mm² at 6 months, 1.85 (0.1) and 1.57 (0.1) mm² at 12 months, and 3.14 (0.4) and 3.17 (0.5) mm² at 18 months. The mean change in lesion size from baseline to month 12 was significantly greater in participants who had eyes with multifocal atrophic spots compared with those with unifocal spots (P < 0.001) and those with extrafoveal lesions compared with those with foveal lesions (P = 0.001). The mean (standard deviation) decrease in visual acuity was 6.2 ± 15.6 letters for patients with image data available. Atrophic lesions with a diffuse (mean 0.95 mm²) or banded (mean 1.01 mm²) FAF pattern grew more rapidly by month 6 compared with those with the “none” (mean, 0.13 mm²) and focal (mean, 0.36 mm²) FAF patterns.

Conclusions

Although differences were observed in mean lesion size measurements using FAF imaging compared with CFP, the measurements were highly correlated with one another. Significant differences were found in lesion progression rates in participants stratified by hyperfluorescence pattern subtype. This large GA natural history study provides a strong foundation for future clinical trials.